S Friman

Author PubWeight™ 56.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007 3.26
2 Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients. Am J Transplant 2007 1.77
3 Liver transplantation for metastatic neuroendocrine tumor disease. Transplant Proc 2003 1.47
4 Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol 1999 1.45
5 Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant 2012 1.42
6 Renal transplantation in the Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. Nephrol Dial Transplant 1991 1.08
7 Pseudoaneurysm of the hepatic artery following liver transplantation. Transplant Proc 2006 1.04
8 Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995 1.02
9 Liver transplantation for polycystic liver disease--indications and outcome. Transplant Proc 2003 1.02
10 Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun 1996 0.98
11 Acetazolamide inhibits stimulated feline liver and gallbladder bicarbonate secretion. Acta Physiol Scand 2002 0.97
12 Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998 0.97
13 Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report. Transplant Proc 2013 0.97
14 Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000 0.96
15 A prospective, randomized, multicenter trial of tacrolimus-based therapy with or without basiliximab in pediatric renal transplantation. Am J Transplant 2006 0.95
16 MELD [corrected] score in patients accepted for liver transplantation 1994 to 2004. Transplant Proc 2006 0.93
17 Role of nitric oxide in motility and secretion of the feline hepatobiliary tract. Scand J Gastroenterol 1995 0.91
18 Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. Scand J Gastroenterol 2003 0.89
19 Interventional treatment of gastrointestinal neuroendocrine tumours. Digestion 2000 0.88
20 Late mortality in 679 consecutive liver transplant recipients: the Gothenburg liver transplant experience. Transplant Proc 2006 0.87
21 Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial. Transplant Proc 2010 0.87
22 One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion. Transplant Proc 2002 0.86
23 Autosomal dominant polycystic kidney disease in a kidney transplant population. Nephrol Dial Transplant 1997 0.86
24 Liver transplantation using cavoportal hemitransposition- a life-saving procedure in the presence of extensive portal vein thrombosis. Transplant Proc 2001 0.86
25 Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet 1990 0.85
26 Progeny of survivors of acute lymphocytic leukemia. Acta Paediatr Scand 1979 0.83
27 Follow-up after liver transplantation for primary sclerosing cholangitis: effects on survival, quality of life, and colitis. Scand J Gastroenterol 1999 0.81
28 Retransplantation of the liver. Transplant Proc 2006 0.81
29 [Control of methicillin resistant staphylococci at the Sahlgrenska hospital. Successful control program against MRSA outbreak]. Lakartidningen 2001 0.80
30 Progressive renal impairment in liver transplant recipients on a cyclosporine-based protocol: 5 year follow-up with glomerular filtration rate measurements. Transplant Proc 1997 0.80
31 Functional and morphological relationships between the feline main pancreatic and bile duct sphincters. Gastroenterology 1990 0.80
32 Treatment with the molecular adsorbent recirculating system in patients with acute liver failure. Transplant Proc 2003 0.80
33 Spectrum of hereditary renal disease in a kidney transplant population. Nephrol Dial Transplant 1995 0.80
34 Calculation and comparison of the model for end-stage liver disease (MELD) score in patients accepted for liver transplantation in 1999 and 2004. Transplant Proc 2007 0.80
35 Liver transplantation in patients over 60 years of age. Transpl Int 2000 0.80
36 The liver protective effect of ischemic preconditioning may be mediated by adenosine. Transpl Int 2000 0.79
37 Prognostic value of pre-transplant cardiomyopathy in Swedish liver transplanted patients for familial amyloidotic polyneuropathy. Amyloid 2011 0.79
38 Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc 2006 0.79
39 Liver transplantation in familial amyloidotic polyneuropathy (FAP). A comparative study of transplanted and non-transplanted patient's survival. Transpl Int 1998 0.79
40 Extended right-sided liver resection for colorectal liver metastases--impact of percutaneous portal venous embolisation. Eur J Surg Oncol 2006 0.79
41 Quality of life after paediatric kidney transplantation: a single-centre experience. Transplant Proc 2001 0.79
42 Early recurrence of nephrotic syndrome (immunoglobulin m nephropathy) after renal transplantation successfully treated with combinations of plasma exchanges, immunoglobulin, and rituximab. Transplant Proc 2006 0.79
43 Raised pressure in the bile ducts after orthotopic liver transplantation. Transpl Int 1994 0.79
44 Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Transplant Proc 2005 0.79
45 Combined liver and kidney transplantation against a positive cross match in a patient with multispecific HLA-antibodies. Transplant Proc 1997 0.78
46 Early outcome of liver transplantation using donors over 60 years of age. Transplant Proc 2001 0.78
47 Pharmacological preconditioning of rat liver by up-regulation of heme oxygenase 1. Transplant Proc 2006 0.78
48 Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 2003 0.78
49 Auxiliary liver and combined kidney transplantation prevents hyperacute kidney rejection in highly sensitized patients. Transplant Proc 2002 0.77
50 Outcome after liver transplantation for primary sclerosing cholangitis. Transplant Proc 2001 0.77
51 Protective effect of nitric oxide and prostaglandin E(2) in ischemia/reperfusion injury of the liver. Transplant Proc 2001 0.77
52 Effect of remote preconditioning on mild or severe ischemia-reperfusion injury to rat liver. Transplant Proc 2006 0.77
53 Preconditioning protects against ischemia/reperfusion injury of the liver. J Gastrointest Surg 2000 0.77
54 Relationship between gallbladder histopathology and ability to concentrate biliary lipids and bilirubin. A study on gallstone patients with functioning gallbladder. Acta Chir Scand 1988 0.77
55 What are we waiting for? Analyses of factors influencing cold ischemia time. Transplant Proc 2010 0.77
56 The ATP/ADP binding domains of actin are conserved in nucleosome complexed with histone H1 and high mobility group-17 protein. Biochem Biophys Res Commun 1995 0.76
57 Long-term follow-up of living liver donors. Transplant Proc 2010 0.76
58 Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut. Transplantation 1994 0.76
59 In situ split liver procedures in cadaver and living-related donors. Transplant Proc 1997 0.76
60 Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. J Hepatol 2001 0.76
61 Liver transplantation using cavoportal hemitransposition: a possibility in the presence of extensive portal vein thrombosis. Transplant Proc 2001 0.75
62 Biliary excretion of 400- to 1,000-d polyethylene glycol will influence the calculation of small intestinal absorption in portacaval-shunted rats. Hepatology 1997 0.75
63 [Liver transplantation from a living donor is now possible. The first cases in Sweden completed with good results]. Lakartidningen 1999 0.75
64 Initial experience with multivisceral, cluster, and combined liver and small bowel transplantation in Sweden. Transplant Proc 2002 0.75
65 Experience from a single institution: 3000 consecutive kidney transplants during 30 years. Transplant Proc 1997 0.75
66 Role of nitric oxide in induction of inflammatory fluid secretion by the mucosa of the feline gallbladder. Gastroenterology 1996 0.75
67 Pretreatment with L-arginine reduces ischemia/reperfusion injury of the liver. Transplant Proc 1997 0.75
68 Enterohepatic bile-acid circulation in the pregnant cat. Acta Physiol Scand 1988 0.75
69 Severe clinical course of de novo hepatitis B infection after liver transplantation. Transplant Proc 2001 0.75
70 Nitric oxide-mediated effects on liver blood flow. Transplant Proc 2005 0.75
71 Liver transplantation for primary sclerosing cholangitis--a single-center experience. Transpl Int 2000 0.75
72 Experiences from the first five-organ multivisceral transplantation in Scandinavia. Transplant Proc 2000 0.75
73 Sympathetic and VIP-ergic control of calcium and bicarbonate transport in the feline gall bladder mucosa in vivo. J Auton Nerv Syst 1996 0.75
74 Adjuvant treatment with ursodeoxycholic acid prevents acute rejection in rats receiving heart allografts. Transpl Int 1992 0.75
75 Selected activities in Scandiatransplant. Transplant Proc 2005 0.75
76 PTLD in liver transplant recipients. Transplant Proc 2001 0.75
77 Influence of liver transplantation and cyclosporin on bile secretion--an experimental study in the rat. Transpl Int 1995 0.75
78 Is a 3-day waiting list appropriate for patients with acute liver failure? Transplant Proc 1994 0.75
79 Combination therapy of interferon alpha-2B and ribavirin for recurrent hepatitis C after liver transplantation. Transplant Proc 2003 0.75
80 Direct measurements of enterohepatic circulation of bile acids in the cat. Influence of contraceptive steroids and oophorectomy. Scand J Gastroenterol 1987 0.75
81 Thrombectomy and in situ fibrinolysis in the treatment of acute hepatic arterial thrombosis after liver transplantation in two children. Eur J Surg 1999 0.75
82 Early function of liver grafts preserved with or without portal perfusion. Transplant Proc 2001 0.75
83 [Liver transplantation--from experiment to routine care. Experiences from the first 500 liver transplantations in Gothenburg]. Lakartidningen 2001 0.75
84 [Liver transplantation in neuroendocrine tumors prolongs symptom-free period, might also be a cure]. Lakartidningen 1999 0.75
85 VIP-antiserum inhibits fluid secretion by the inflamed gallbladder mucosa. Regul Pept 1994 0.75
86 Endoluminal laser-Doppler measurements of jejunal perfusion in patients undergoing liver transplantation. Transpl Int 2001 0.75
87 Role of cyclooxygenase-2 for fluid secretion by the inflamed gallbladder mucosa. J Gastrointest Surg 1999 0.75
88 Outcome of renal transplantation subsequent to liver, heart, or lung transplantation. Transplant Proc 2006 0.75
89 Inflammation reduces mucosal secretion of hydrogen ions and impairs concentrating function and luminal acidification in feline gallbladder. Scand J Gastroenterol 1995 0.75
90 Paediatric living related donor liver transplantation: experiences from Gothenburg, Sweden. Transplant Proc 2001 0.75
91 Cyclosporine influences liver function as measured by IODIDA clearance rate: a study in liver and kidney transplant patients, and healthy volunteers. Transplant Proc 1997 0.75
92 Organ transplantation in Göteborg with particular reference to kidney transplantation. Clin Transpl 1993 0.75
93 Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis. Transplant Proc 2005 0.75
94 The cadaveric organ donor program at Sahlgrenska University Hospital, 1977 to 2005. Transplant Proc 2006 0.75
95 In vivo regulation of mucosal transport of H+ and HCO3- in the feline gall bladder. Acta Physiol Scand 1993 0.75
96 The influence of pregnancy and contraceptive steroids on the biliary tract and its reference to cholesterol gallstone formation. Scand J Gastroenterol 1990 0.75
97 Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect? Transplant Proc 2001 0.75
98 Glomerular filtration rate after liver transplantation with a low-dose cyclosporin protocol. Transpl Int 1994 0.75
99 VIP-antiserum and indomethacin inhibit calcium and bicarbonate secretion by the inflamed feline gallbladder mucosa. Acta Physiol Scand 1996 0.75
100 Multivisceral transplantation in Scandinavia: experiences from the first successful five-organ case. Transplant Proc 2001 0.75
101 Clean intermittent catheterisation in kidney transplanted children with abnormal lower urinary tracts. Transplant Proc 1995 0.75
102 Time to request ABO-identity when transplanting for fulminant hepatic failure? Transplant Proc 2001 0.75
103 Excellent liver transplantation survival and prevention of hepatitis B recurrence using hepatitis B immunoglobulin and nucleoside or nucleotide analogue along with treating physician adherence to treatment protocol. Transplant Proc 2013 0.75
104 Orthotopic liver transplantation in patients with hepatitis B-related liver disease. Transplant Proc 2001 0.75
105 Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplant Proc 1995 0.75
106 Renal function after liver transplantation. Transplant Proc 2001 0.75
107 Conversion to sirolimus after kidney and liver transplantation: indications and outcomes. Transplant Proc 2003 0.75
108 Survival after liver transplantation for cholangiocarcinoma has increased during the last decade. Transplant Proc 2003 0.75
109 Adjuvant ursodeoxycholic acid prevents acute rejection in liver transplant recipients. Transplant Proc 1991 0.75
110 Hepatocyte and Kupffer cell function after liver transplantation in the rat--in vivo evaluation with dynamic scintigraphy. Liver 1995 0.75